Cognex Corporation — Q2 2014 Form 10-Q
Reporting period: Quarter ended June 29, 2014; interim financial statements are unaudited. Cognex develops machine-vision products for manufacturing automation and reports Modular Vision Systems (MVSD) and Surface Inspection Systems (SISD).
Financial performance
| Metric | Q2 2014 | Q2 2013 | Six months 2014 | Six months 2013 |
|---|---|---|---|---|
| Revenue | $108.8 million | $86.5 million | $199.7 million | $167.4 million |
| Gross margin | $83.0 million; 76% | $65.4 million; 76% | $152.9 million; 77% | $126.8 million; 76% |
| Operating income | $30.7 million; 28% of revenue | $20.2 million; 23% | $53.2 million | $38.2 million |
| Net income | $25.9 million | $16.8 million | $44.5 million | $32.4 million |
| Diluted EPS | $0.29 | $0.19 | $0.50 | $0.37 |
| Operating cash flow | — | — | $31.7 million | $39.0 million |
Q2 revenue increased 26% year over year and six-month revenue increased 19%. Growth came from all three markets, led by factory automation; Q2 factory automation, semiconductor/electronics capital equipment, and surface inspection represented 77%, 8%, and 15% of revenue, respectively. Q2 product revenue rose 29%, while service revenue declined 14%. For the first half, operating expenses rose 13%: R&D increased 13% and SG&A 12%.
At June 29, cash and cash equivalents were $40.2 million and investments were $427.4 million, totaling $467.6 million, versus $455.1 million at year-end 2013. The company reported no debt and said liquidity and operating cash flow should meet requirements for the next 12 months. Current assets were $268.3 million and current liabilities $74.1 million. First-half capital expenditures were $5.3 million. Operating cash flow fell year over year, with higher receivables, inventory, and deferred costs among the drivers.
Changes, outlook, and notable items
- Management attributed higher product margins to MVSD manufacturing efficiencies and purchasing-volume benefits. Service margin declined, mainly because of lower SISD installation margins.
- Management expected significant factory-automation revenue from a single customer in Q3 2014. It also said semiconductor/electronics demand remained cyclical with limited visibility. No formal company-wide revenue or earnings guidance is provided in the filing.
- A customer arrangement generated substantial inventory costs: $20.9 million of deferred costs was on the balance sheet because revenue-recognition criteria were not met by quarter-end. Management expected to collect the arrangement fee in the second half of 2014.
- Cash used for share repurchases was $27.0 million in the first half. The board authorized an additional $50 million repurchase program, to begin after completion of the existing $80 million authorization. No cash dividends were paid in the first half.
- The effective tax rate was 18% for the first half. A $553,000 tax benefit related to the closure of the IRS audit for 2010–2011; management said additional reserve releases of approximately $500,000–$600,000 could reduce tax expense over the next 12 months.
- In the Microscan patent case, a jury awarded Cognex $2.6 million for willful infringement. The court denied Cognex’s treble-damages motion, granted a limited permanent injunction and attorneys’ fees in part, and the parties awaited final judgment. Other cited patent disputes were closed.
- Key risks include customer and market concentration, cyclical semiconductor/electronics demand, foreign-exchange exposure, supplier and product-quality risks, competition, intellectual-property litigation, and tax uncertainty. Management reported disclosure controls were effective and no material change in internal control over financial reporting.
Important facts for investors to verify
- Whether the anticipated Q3 factory-automation order from one customer occurred, and its effect on subsequent revenue and customer concentration.
- Timing of revenue recognition and collection for the arrangement associated with $20.9 million of deferred costs.
- Final outcome and financial impact of the Microscan judgment, including attorneys’ fees and the injunction.
- Whether first-half operating cash-flow pressure from receivables, inventory, and deferred costs reverses as expected.
- Progress on the existing and newly authorized share repurchase programs and their effect on cash and diluted share count.
- Potential tax-reserve releases and the company’s exposure to the risks described in its annual report.